Tilray Brands (NASDAQ:TLRY) Stock Rating Upgraded by Roth Mkm

Tilray Brands (NASDAQ:TLRY) was upgraded by Roth Mkm from a “neutral” rating to a “buy” rating in a report released on Thursday, MarketBeat reports. The firm presently has a $10.00 price target on the stock. Roth Mkm’s target price would indicate a potential upside of 62.87% from the stock’s current price.

Several other equities analysts have also recently weighed in on the stock. TD Cowen dropped their price target on shares of Tilray Brands from $10.00 to $7.00 and set a “buy” rating on the stock in a research report on Monday. Zacks Research raised Tilray Brands from a “strong sell” rating to a “hold” rating in a report on Wednesday, February 11th. ATB Cormark Capital Markets upgraded shares of Tilray Brands from a “strong sell” rating to a “hold” rating in a research report on Wednesday, December 10th. Wall Street Zen raised shares of Tilray Brands from a “sell” rating to a “hold” rating in a research report on Saturday, March 21st. Finally, Canaccord Genuity Group initiated coverage on shares of Tilray Brands in a research note on Tuesday, January 27th. They issued a “hold” rating on the stock. Three equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $11.75.

Tilray Brands Stock Down 5.1%

TLRY stock opened at $6.14 on Thursday. The stock’s 50 day simple moving average is $7.37 and its 200 day simple moving average is $10.25. The company has a market cap of $715.35 million, a P/E ratio of -0.28 and a beta of 1.96. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.72 and a current ratio of 2.81. Tilray Brands has a fifty-two week low of $3.51 and a fifty-two week high of $23.20.

Tilray Brands (NASDAQ:TLRY) last released its quarterly earnings data on Thursday, January 8th. The company reported ($0.02) EPS for the quarter, beating the consensus estimate of ($0.14) by $0.12. Tilray Brands had a negative return on equity of 6.35% and a negative net margin of 251.69%.The firm had revenue of $217.51 million during the quarter, compared to the consensus estimate of $211.15 million. During the same quarter in the previous year, the company posted ($0.03) earnings per share. On average, research analysts expect that Tilray Brands will post -0.2 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Tilray Brands

Several institutional investors have recently added to or reduced their stakes in the business. Hilton Head Capital Partners LLC purchased a new position in shares of Tilray Brands in the fourth quarter worth about $38,000. Schonfeld Strategic Advisors LLC boosted its holdings in Tilray Brands by 4.5% in the 4th quarter. Schonfeld Strategic Advisors LLC now owns 144,358 shares of the company’s stock worth $1,304,000 after buying an additional 6,182 shares during the period. IFP Advisors Inc boosted its holdings in Tilray Brands by 14.3% in the 4th quarter. IFP Advisors Inc now owns 60,318 shares of the company’s stock worth $545,000 after buying an additional 7,541 shares during the period. Integrated Wealth Concepts LLC grew its stake in Tilray Brands by 33.8% in the 3rd quarter. Integrated Wealth Concepts LLC now owns 36,977 shares of the company’s stock valued at $64,000 after buying an additional 9,341 shares in the last quarter. Finally, CreativeOne Wealth LLC grew its stake in Tilray Brands by 12.2% in the 3rd quarter. CreativeOne Wealth LLC now owns 87,134 shares of the company’s stock valued at $151,000 after buying an additional 9,452 shares in the last quarter. 9.35% of the stock is owned by hedge funds and other institutional investors.

Key Headlines Impacting Tilray Brands

Here are the key news stories impacting Tilray Brands this week:

• Positive Sentiment: Record revenue and top-line beat — Tilray reported roughly $206.7–$207M in Q3 revenue (about +11% organic) and beat consensus, with gross profit rising to ~$55M, showing improvement in core sales. Tilray Brands Delivers Record Q3 Fiscal 2026 Results
• Positive Sentiment: Strong international cannabis growth — management highlighted a 73% increase in international cannabis revenue and a 100% rise in flower volume year-over-year, supporting the company’s global cannabis thesis. Tilray Brands Delivers Record Q3 Fiscal 2026 Results (Yahoo)
• Positive Sentiment: Strategic beverage and brand moves — Tilray closed the BrewDog acquisition (~£40M) and is expanding branded RTD offerings (Popsicle partnership, new Shock Top SKU), which could boost longer-term beverage scale if margins improve. Is Tilray Among the 11 Best Marijuana Stocks? (InsiderMonkey)
• Neutral Sentiment: Company reaffirmed FY26 outlook — management kept guidance intact, which removes some downside but didn’t materially exceed street expectations. Tilray Brands reaffirms outlook after record quarter
• Neutral Sentiment: Earnings call highlighted strategy and execution challenges — management discussed growth initiatives and margin work in beverages and international markets; these are strategic positives but will take time to convert to improved margins. Tilray Brands Inc Q3 2026 Earnings Call Highlights
• Negative Sentiment: Analyst downgrade and tempered expectations — TD Cowen and other firms reduced targets/expectations, weighing on sentiment and amplifying the sell-off. TD Cowen Has Lowered Expectations for Tilray Brands
• Negative Sentiment: Mixed profitability and margin pressure — despite narrower losses, some outlets flagged a Q3 EPS miss or continued GAAP losses and a deeply negative net margin, keeping investor concerns about near-term profitability elevated. Tilray Reports Q3 Loss, Beats Revenue Estimates (Zacks)
• Negative Sentiment: Immediate market reaction was negative — several market pieces explain the sell-off (profitability skepticism, beverage margin concerns, and analyst actions) despite the revenue beat. Tilray Sinks 4%: 3 Reasons the Market Isn’t Impressed (Yahoo)

About Tilray Brands

Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.

Tilray’s product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.